Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rxo (RXO) Other Non-Current Liabilities (2021 - 2025)

Historic Other Non-Current Liabilities for Rxo (RXO) over the last 5 years, with Q4 2025 value amounting to $69.0 million.

  • Rxo's Other Non-Current Liabilities fell 1686.75% to $69.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $69.0 million, marking a year-over-year decrease of 1686.75%. This contributed to the annual value of $69.0 million for FY2025, which is 1686.75% down from last year.
  • According to the latest figures from Q4 2025, Rxo's Other Non-Current Liabilities is $69.0 million, which was down 1686.75% from $71.0 million recorded in Q3 2025.
  • Rxo's Other Non-Current Liabilities' 5-year high stood at $88.0 million during Q1 2025, with a 5-year trough of $36.0 million in Q3 2022.
  • In the last 5 years, Rxo's Other Non-Current Liabilities had a median value of $41.0 million in 2024 and averaged $52.9 million.
  • The largest annual percentage gain for Rxo's Other Non-Current Liabilities in the last 5 years was 11463.41% (2025), contrasted with its biggest fall of 1686.75% (2025).
  • Over the past 5 years, Rxo's Other Non-Current Liabilities (Quarter) stood at $37.0 million in 2021, then rose by 8.11% to $40.0 million in 2022, then changed by 0.0% to $40.0 million in 2023, then surged by 107.5% to $83.0 million in 2024, then dropped by 16.87% to $69.0 million in 2025.
  • Its last three reported values are $69.0 million in Q4 2025, $71.0 million for Q3 2025, and $70.0 million during Q2 2025.